voice search
Erlonat 150 Tablet - 150mg, Anti-cancer Medication For Non-small Cell Lung And Pancreatic Cancer Treatment | Contains Erlotinib, Suitable For Empty Stomach Use, 2 Years Shelf Life

Erlonat 150 Tablet - 150mg, Anti-cancer Medication For Non-small Cell Lung And Pancreatic Cancer Treatment | Contains Erlotinib, Suitable For Empty Stomach Use, 2 Years Shelf Life

Price: 5000.00 INR / Pack

(5000.00 INR + 0% GST)

Get Latest Price

1 Pack Contains :

1

Minimum Pack Size :

50

In Stock

In Stock

-50+

Product Specifications

Drug TypeSpecific Drug
IngredientsERLOTINIB
Physical FormTablets
FunctionCancer Treatment
Dosage100MG , 150MG
Storage Instructions10-30AdegC
Payment TermsTelegraphic Transfer (T/T)
Supply Ability200 Per Month
Delivery Time8 - 10 Days
Packaging Details30 TABLETS / PACK
Main Export Market(s)Australia, North America, South America, Eastern Europe, Western Europe, Central America, Asia, Africa
Main Domestic MarketAll India
Moq50
Unit TypePack/Packs
Price5000.00 INR (Approx.)
Stock Quantity150
CurrencyINR
Mop50
ReturnableNo
Packsize1
Price Typefixed
Product Unit50 Pack/Packs
Brand NameERLONAT
Minimum Order Quantity50
Minimum Ordered Packs50
GSTIN0%

Company Details

The importance of healthcare in the society cannot be denied. Medical technology has been experiencing unprecedented progress in recent years, making the future look easier for doctors and caregivers. One can witness how the global healthcare sector has accelerated progress when it comes to dealing with deadly diseases like HIV, asthma and cancer. New breakthroughs and advancements in the field of oncology and other areas are here to help healthcare professionals and their patients experience better outcomes like never before. Making better health outcomes accessible for patients and healthcare experts across wider geographical areas is Niba Healthcare – a licensed exporter, trader and supplier of Anticancer Medicine And Injections, Oncology Drugs And Injections, Skin Care Creams And Ointments, Asthma Inhalers, Anti HIV Medicines, High Blood Pressure Drugs, Anti Acne Creams And Ointments, etc. Speedier recovery from even the most debilitating of diseases and quicker return to one’s normal life is what the company assures to the public as it works round the clock to make a difference in its field. Partnering with some of the leading vendors in the segment, it sources safe and effective medicines and drugs to promise quality of life to millions of consumers around the world on a daily basis.

Contact the company today to see how it has opened the door to a healthier life for so many people across the world.

Company Goals

There are thousands of consumers who have benefitted from its trading and export business. Patrons from both the Indian and global market hold the company in high esteem as it strives towards these goals:

  • - Adhering to GMP and ISO 9001:2015 standards
  • - Finding better healthcare treatments in the market
  • - Identifying medicine vendors with efficient delivery systems, and high-tech equipment
  • - Giving consumers quick access to less costly branded medications like Anticancer Medicine And Injections, Oncology Drugs And Injections, Skin Care Creams And Ointments, Asthma Inhalers, Anti HIV Medicines, High Blood Pressure Drugs, Anti Acne Creams And Ointments, etc.

Leadership

Mr Nishant Barethiya began his role as the Owner and Proprietor of Niba Healthcare in the year 2018. His aim was to collaborate with leading medicine brands and pave the path towards excellent patient care everywhere. He has faced many unique challenges but they have never deterred him from losing sight of his focus, which is to effectively tailor care for patients with severe health conditions like HIV, asthma, cancer, blood pressure and various skin diseases. His perseverance and valuable contributions have over the years helped the company achieve greatness in its field, and herald new transformations in the field of global healthcare.

Why Choose Niba Healthcare?

  • - Vendors: One would always find vendors who lack the will to honour quality commitments, take timely actions or remain ethically and morally grounded when dealing with partners. Thankfully, our vendors are not one of them. In fact, we can operate with agility and resilience because of our vendors, who never take shortcuts for personal gains and timely deliver us with effective and safe medicines that are formulated to treat HIV, asthma, cancer, blood pressure and various skin conditions.
  • - Pricing: Good pricing is expected from market-leading medicine traders that have wellbeing at the core of their businesses. We too have garnered trust and respect from many consumers around the world for our fair pricing policy. We are inspired by customer contentment and sell our entire range of Anticancer Medicine And Injections, Oncology Drugs And Injections, Skin Care Creams And Ointments, Asthma Inhalers, Anti HIV Medicines, High Blood Pressure Drugs, Anti Acne Creams And Ointments, etc., at affordable prices for the convenience of our customers.
  • - Delivery: Medicine traders need to carry out multiple works simultaneously without compromising deadlines, ever. Any inconvenience caused to a buyer because of a delayed delivery might lead to the trader losing his reputation in the industry for good. Therefore, we always dispatch orders on time and give due attention to this most important aspect of our work- delivery timing. In fact, we are known for completing small to big tasks ahead of schedules.


Vision

The company hopes to emerge as a talented market leader that knows how to harness its innate ability and respond to healthcare needs globally with excellence while playing on its effective trade partnerships, optimised supply chain and client-centred work strategies.


Mission

Our mission is to create enduring value that benefits both the company and our worldwide customers.


Fact Sheet of Niba Healthcare

Nature of Business

Trader, Supplier & Exporter

Business Location

Nagpur, Maharashtra, India

Proprietor

Mr. Nishant Barethiya

Year of Establishment

2018

No. of Employees

10

Ownership Type

Proprietorship Company

GST No.

27BFAPB0168Q1ZD

IE Code

BFAPB0168Q

Annual Turnover

INR 5 Crore

Banker

Kotak Mahindra Bank

Standard Certification

FDA Maharashtra

Business Type

Exporter, Supplier, Trading Company

Employee Count

15

Establishment

2018

Working Days

Monday To Saturday

GST NO

27BFAPB0168Q1ZD

Payment Mode

Telegraphic Transfer (T/T)

Certification

ISO 9001:2015 , WHO-GMP

Related Products

Explore Related Categories

More Products From This Seller

Seller Details

GST

GST - 27BFAPB0168Q1ZD

4 RatingRating
Trusted SellerTrustedSeller
super premium

Nagpur, Maharashtra

Seller Inquiry

Accepts only Foreign inquiries

Proprietor

Mr Nishant Barethiya

Members since

7 Years

Address

Plot No.57, Koradi Road, Bokhara, Near Modern School, Nagpur, Maharashtra, 441111, India

erlotinib tablets in Nagpur

Report incorrect details

Compare With Similar Products

Buyer Feedback

4

5

3

Price Or Price Range

5000 INR (Approx.)

1700.00 - 7200.00 INR (Approx.)

122.96-136.63 USD ($) (Approx.)

Minimum Order Quantity

5 Pack/Packs

1 Bottle/Bottles

2 Bottle/Bottles

Drug Type

Specific Drug

Specific Drug

Ingredients

ERLOTINIB

ERLOTINIB 150

Physical Form

Tablets

Tablets

Function

Cancer Treatment

Cancer Treatment

Dosage

100MG , 150MG

The recommended daily dose of TARCEVA for NSCLC is 150 mg taken on an empty stomach, i.e., at least one hour before or two hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs. Recommended Dose - Pancreatic Cancer The recommended daily dose of TARCEVA for pancreatic cancer is 100 mg taken once daily in combination with gemcitabine. Take TARCEVA on an empty stomach, i.e., at least one hour before or two hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs [see Clinical Studies]. Dose Modifications Adverse Reactions PulmonaryaEUR Interstitial Lung Disease (ILD) Discontinue TARCEVA During diagnostic evaluation for possible ILD Withhold TARCEVA* HepaticaEUR Severe hepatic toxicity that does not improve significantly or resolve within three weeks Discontinue TARCEVA In patients with pre-existing hepatic impairment or biliary obstruction for doubling of bilirubin or tripling of transaminases values over baseline Withhold TARCEVA* and consider discontinuation In patients without pre-existing hepatic impairment for total bilirubin levels greater than 3 times the upper limit of normal or transaminases greater than 5 times the upper limit of normal Withhold ERLONAT and consider

Storage Instructions

10-30AdegC

ROOM TEMP. 10 -30 C

Payment Terms

Telegraphic Transfer (T/T)

Cash in Advance (CID)

Supply Ability

200 Per Month

10000 Per Week

20 Per Week

Delivery Time

8 - 10 Days

1 Days

2 Week

Packaging Details

30 TABLETS / PACK

1*30S

Main Export Market(s)

Australia, North America, South America, Eastern Europe, Western Europe, Central America, Asia, Africa

Australia, South America, Middle East, Africa, Western Europe, Asia, Central America, Eastern Europe, North America

Main Domestic Market

All India

All India